Transcatheter aortic valve implantation for the treatment of surgical valve dysfunction ("valve-in-valve"): assessing the risk of coronary obstruction

Marina Urena; Luis Nombela-Franco; Daniel Doyle; Robert De Larochellière; Eric Dumont; Jacques Villeneuve; Sergio M Pasian; Michel Gingras; Michael Mok; Josep Rodés-Cabau

doi:10.1111/jocs.12003

Transcatheter aortic valve implantation for the treatment of surgical valve dysfunction ("valve-in-valve"): assessing the risk of coronary obstruction

J Card Surg. 2012 Nov;27(6):682-5. doi: 10.1111/jocs.12003. Epub 2012 Sep 27.

Authors

Marina Urena¹, Luis Nombela-Franco, Daniel Doyle, Robert De Larochellière, Eric Dumont, Jacques Villeneuve, Sergio M Pasian, Michel Gingras, Michael Mok, Josep Rodés-Cabau

Affiliation

¹ Quebec Heart & Lung Institute, Laval University, Quebec city, Quebec, Canada.

PMID: 23016913
DOI: 10.1111/jocs.12003

Abstract

Acute coronary obstruction is one of the most feared complications associated with transcatheter aortic valve-in-valve implantation. Strategies for assessing the risk of coronary occlusion during these procedures as well as preventive measures are discussed.

Publication types

Case Reports

MeSH terms

Acute Disease
Aged, 80 and over
Aortic Valve Insufficiency / surgery*
Bioprosthesis
Cardiac Catheterization
Coronary Occlusion / etiology
Coronary Occlusion / prevention & control*
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation / adverse effects
Heart Valve Prosthesis Implantation / methods*
Humans
Male
Risk
Risk Assessment*
Treatment Outcome